Nurse Practitioner in Loxley, AL Accepting Medicare
4 Nurse Practitioner nurses found. Showing 1 - 4
 Matthew Dorsett, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 27572 County Road 66 N, Loxley, AL 36551 Phone: 251-234-9209 |
 Ms. Brandy Nicholson, Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 1083 E Relham Dr, Loxley, AL 36551 Phone: 251-964-4011 Fax: 251-964-4012 |
Kelli Gillman, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1083 E Relham Dr, Loxley, AL 36551 Phone: 251-964-4011 Fax: 251-964-4012 |
Shandi Shiver, CRNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 1083 E Relham Ave, Loxley, AL 36551 Phone: 251-964-4011 |
News Archive
CK5 protein marks ovarian cancer likely to be resistant to cisplatin
A University of Colorado Cancer Center study recently published in the International Journal of Gynecological Cancer shows that protein cytokeratin 5 (CK5), known to be a marker of poor prognosis in breast cancer, also marks ovarian cancers likely to be resistant to the common chemotherapy cisplatin.
People under 40 diagnosed with Type 2 diabetes have excess risks of dying from or developing heart disease
People under age 40 who are diagnosed with Type 2 diabetes are more likely to have or die from cardiovascular disease than those of similar age without diabetes and the excess risks were more pronounced in younger women, according to new research in the American Heart Association's journal Circulation.
DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight
DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.
Study ultimately could lead to development of screening test for diagnosing bladder cancer
Findings from a Loyola University Medical Center study ultimately could lead to tests to screen for and diagnose bladder cancer.
Oncolytics completes patient enrollment in phase II metastatic pancreatic cancer study
Oncolytics Biotech Inc. today announced completion of patient enrollment in a two-arm randomized phase II study of carboplatin, paclitaxel plus REOLYSIN versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer (OSU-10045).
› Verified 6 days ago